4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000219
Director sold 59,441 shares at an average $32.51 ($1,932,665)
- Director acquired 47,165 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Schenkein David P · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +47,165 | $18.00 | $848,970 | 68,661 | D |
| 2024-11-11 | Sale : show line 2 in the form 10b5-1 | −27,129 | $32.09 | $870,570 | 41,532 | D |
| 2024-11-11 | Sale : show line 3 in the form 10b5-1 | −32,312 | $32.87 | $1,062,095 | 9,220 | D |
| Open-market sales · 59,441 sh · avg $32.51 · $1,932,665 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-11 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −47,165 | 0 | D |
Loading xslF345X05/wk-form4_1731532732.xml…